Kenneth Hallock serves as Executive at Greenwich LifeSciences, Inc., where they oversee executive responsibilities. Since joining the company, Kenneth Hallock has executed 8 insider transactions totaling $484.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2022 involved purchasing 300 shares valued at $4.9K.
Kenneth Hallock currently holds 397,304 shares of Greenwich LifeSciences, Inc. (GLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Hallock has been a net buyer of GLSI stock. They have purchased $484.0K and sold $0 worth of shares.
Kenneth Hallock's most recent insider trade was on Jan 21, 2022, when they purchased 300 shares at $16.32 per share.
Get notified when new Form 4 filings are submitted
| $5.39 |
| Discretionary |
| Nov 20, 2020 | GLSI | $5.4K | Purchase | 1,000 | $5.37 | Discretionary |
| Sep 29, 2020 | GLSI | $38.3K | Purchase | 8,333 | $4.60 | Discretionary |
| Sep 29, 2020 | GLSI | $430.0K | Purchase | 74,782 | $5.75 | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 79,121 | $N/A | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 18,727 | $N/A | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 18,727 | $N/A | Discretionary |